Berlin, Germany

Uwe Muenster

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uwe Muenster. Retrieved from https://idiyas.com/inventor/uwe-muenster-e7x2555u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Uwe Muenster: Innovator in Antiandrogenic Treatments

Introduction

Uwe Muenster is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for androgenic conditions. His innovative work has led to the creation of a patent that addresses important health issues.

Latest Patents

Uwe Muenster holds a patent for "Preparations for topical administration of substances having antiandrogenic activity." This preparation includes at least one form of lipid nanoparticles or a nanoemulsion containing compounds suitable for treating androgenic alopecia and hirsutism. The formulation is designed to prevent unwanted hair growth and is also applicable in treating seborrhea and acne. This patent highlights his commitment to advancing medical treatments through innovative formulations.

Career Highlights

Muenster is associated with Aventis Pharma Deutschland GmbH, where he has contributed to various research and development projects. His work has focused on creating effective solutions for dermatological conditions, showcasing his expertise in pharmaceutical sciences. His dedication to innovation has positioned him as a key figure in his field.

Collaborations

Uwe Muenster has collaborated with notable colleagues, including Karl Theodor Kraemer and Karl-Heinz Nietsch. These partnerships have fostered a collaborative environment that enhances the development of new treatments and technologies.

Conclusion

Uwe Muenster's contributions to the field of antiandrogenic treatments exemplify the impact of innovative thinking in pharmaceuticals. His patent and collaborative efforts reflect a commitment to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…